Search research articles
Contact Us
Filters
Showing results (31-40 of 64) with videos related to
Page
of 7
Sort By:
Oncogene
|
June 27, 2002
Induction of apoptosis by the new anticancer drug XK469 in human ovarian cancer cell lines
Zhenhua Ding, Jun-Ying Zhou, Wei-Zen Wei, et al.
Pediatric Blood & Cancer
|
August 30, 2008
High level of mitogen-activated protein kinase phosphatase-1 expression is associated with cisplatin resistance in osteosarcoma
Zhihong Wang, Jun-Ying Zhou, Deepa Kanakapalli, et al.
Frontiers in Oncology
|
August 9, 2021
Analysis of Adaptive Olaparib Resistance Effects on Cisplatin Sensitivity in Triple Negative Breast Cancer Cells
Ambikai Gajan, Ashapurna Sarma, Seongho Kim, et al.
Molecular and Cellular Biology
|
May 8, 2019
GP78 Cooperates with Dual-Specificity Phosphatase 1 To Stimulate Epidermal Growth Factor Receptor-Mediated Extracellular Signal-Regulated Kinase Signaling
Dhong Hyo Kho, Mohammed Hafiz Uddin, Madhumita Chatterjee, et al.
Oncotarget
|
November 17, 2018
Erratum: Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivity
Kelly K Haagenson, Jessica Wei Zhang, Zhengfan Xu, et al.
Oncotarget
|
March 25, 2014
Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivity
Kelly K Haagenson, Jessica Wei Zhang, Zhengfan Xu, et al.
The Journal of Biological Chemistry
|
October 9, 2013
Regulation of the Src-PP2A interaction in tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis
Jing Xu, Zhengfan Xu, Jun-Ying Zhou, et al.
Cell Cycle (Georgetown, Tex.)
|
February 4, 2020
Targeting PP2A inhibits the growth of triple-negative breast cancer cells
Mohammed Hafiz Uddin, Julio M Pimentel, Madhumita Chatterjee, et al.
Cancer Letters
|
September 6, 2015
Notch signaling: an emerging therapeutic target for cancer treatment
Xun Yuan, Hua Wu, Hanxiao Xu, et al.
Cell Cycle (Georgetown, Tex.)
|
January 1, 2015
The role of Cullin3-mediated ubiquitination of the catalytic subunit of PP2A in TRAIL signaling
Jing Xu, Jun-Ying Zhou, Zhengfan Xu, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 64) with videos related to
Sort By:
Page
of 7
Oncogene
|
June 27, 2002
Induction of apoptosis by the new anticancer drug XK469 in human ovarian cancer cell lines
Zhenhua Ding, Jun-Ying Zhou, Wei-Zen Wei, et al.
Pediatric Blood & Cancer
|
August 30, 2008
High level of mitogen-activated protein kinase phosphatase-1 expression is associated with cisplatin resistance in osteosarcoma
Zhihong Wang, Jun-Ying Zhou, Deepa Kanakapalli, et al.
Frontiers in Oncology
|
August 9, 2021
Analysis of Adaptive Olaparib Resistance Effects on Cisplatin Sensitivity in Triple Negative Breast Cancer Cells
Ambikai Gajan, Ashapurna Sarma, Seongho Kim, et al.
Molecular and Cellular Biology
|
May 8, 2019
GP78 Cooperates with Dual-Specificity Phosphatase 1 To Stimulate Epidermal Growth Factor Receptor-Mediated Extracellular Signal-Regulated Kinase Signaling
Dhong Hyo Kho, Mohammed Hafiz Uddin, Madhumita Chatterjee, et al.
Oncotarget
|
November 17, 2018
Erratum: Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivity
Kelly K Haagenson, Jessica Wei Zhang, Zhengfan Xu, et al.
Oncotarget
|
March 25, 2014
Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivity
Kelly K Haagenson, Jessica Wei Zhang, Zhengfan Xu, et al.
The Journal of Biological Chemistry
|
October 9, 2013
Regulation of the Src-PP2A interaction in tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis
Jing Xu, Zhengfan Xu, Jun-Ying Zhou, et al.
Cell Cycle (Georgetown, Tex.)
|
February 4, 2020
Targeting PP2A inhibits the growth of triple-negative breast cancer cells
Mohammed Hafiz Uddin, Julio M Pimentel, Madhumita Chatterjee, et al.
Cancer Letters
|
September 6, 2015
Notch signaling: an emerging therapeutic target for cancer treatment
Xun Yuan, Hua Wu, Hanxiao Xu, et al.
Cell Cycle (Georgetown, Tex.)
|
January 1, 2015
The role of Cullin3-mediated ubiquitination of the catalytic subunit of PP2A in TRAIL signaling
Jing Xu, Jun-Ying Zhou, Zhengfan Xu, et al.
Page
of 7